HBM Healthcare Investments AG

HBM Healthcare Investments AG is a Swiss closed-ended investment company specializing in the global healthcare sector. The company holds a diversified portfolio comprising both private and publicly listed entities, with a focus on innovative businesses in biotechnology, medical technology, diagnostics, and health IT. HBM Healthcare Investments AG primarily targets growth-stage companies with proven concepts or clinical milestones, providing capital during pivotal phases of business development. This strategy enables the company to support firms from initial clinical trials through to potential market entry, trade sales, or public offerings. With assets managed through its wholly owned subsidiary, HBM Healthcare Investments (Cayman) Ltd., the company employs dedicated investment teams and leverages a global industry network. Its portfolio spans North America, Asia, and Europe, reflecting worldwide demographic trends and technological advancements in healthcare. HBM Healthcare Investments AG plays a key role in connecting capital with innovation across the life sciences industry, aiming for long-term capital growth through active portfolio management and strategic engagement with its investments.